Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors
- 1 June 1993
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 92 (2-3) , 73-79
- https://doi.org/10.1007/bf01244867
Abstract
Summary In studies on peripheral dopamine (DA) turnover in our department evidence has accumulated that changes in adrenal DA levels induced by varying degrees of neurogenic stimulation roughly reflect changes in the catecholamine (CA) synthesis rate. The question arises if changes in DA levels in rat adrenals induced by different DA D-2 receptor agonists and previously reported from our laboratory, also indicate changes in CA synthesis. After various periods of drug administration rats were killed by decapitation and tissue CA levels in adrenals and forebrain were determined by HPLC-EC. The potent inhibitor of DA-β-hydroxylase FLA 63 (40 mg/kg i.p.) increased adrenal DA by 186% after 1 h and by 423% after 3 h. The DA D-2 agonist quinpirole (0.2 mg/kg s.c, 30 min) itself increased adrenal DA by 55–60% compared to control. In FLA 63 pretreated rats quinpirole increased adrenal DA levels by further 127% (FLA 63 — 1 h), resp. 122% (FLA 63 — 3h) than did FLA 63 itself. The DA D-2 receptor antagonist domperidone (3 mg/kg s.c, 150 min) blocked the quinpirole effect both in saline and FLA 63 (3 h) pretreated rats. Adrenal DOP AC was changed in similar manner as adrenal DA in FLA 63 pretreated rats. No significant changes either in adrenal NA or A were observed after FLA 63 pretreatment. Under the present experimental conditions adreanal DA may thus mainly be looked upon as an intermediate in the synthesis of NA and A, and the elevation of DA induced by DA D-2 receptor stimulation as a consequence of increased catecholamine synthesis.Keywords
This publication has 13 references indexed in Scilit:
- Dopamine receptors, controlling dopamine levels in rat adrenal glands ? comparison with central dopaminergic autoreceptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- Comparison of gene expression of the dopamine D-2 receptor and DARPP-32 in rat brain, pituitary and adrenal glandEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonistsEuropean Journal of Pharmacology, 1990
- Dopamine D2 receptor binding in adrenal medulla: Characterization using [3H]spiperoneBiochemical Pharmacology, 1987
- D2Dopamine Receptors on Bovine Chromaffin Cell Membranes: Identification and Characterization by [3H]N-Methylspiperone BindingJournal of Neurochemistry, 1987
- Characterization of a Dopaminergic Receptor that Modulates Adrenomedullary Catecholamine ReleaseJournal of Neurochemistry, 1986
- Studies on the neurogenic short-term control of adrenomedullary hormone synthesisJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1974
- The adrenal dopamine as an indicator of adrenomedullary hormone biosynthesisNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1972
- Studies on central and peripheral noradrenaline neurons using a new dopamine-β-hydroxylase inhibitorEuropean Journal of Pharmacology, 1970
- On the significance of central noradrenaline for motor activity: Experiments with a new dopamine β-hydroxylase inhibitorEuropean Journal of Pharmacology, 1969